Bausch Health Americas, Inc.
Clinical trials sponsored by Bausch Health Americas, Inc., explained in plain language.
-
New pill tested to calm inflamed bowels
Disease control CompletedThis study tested whether a daily oral pill called amiselimod could help adults with mild to moderate ulcerative colitis. For 12 weeks, 322 participants received either the study drug or a placebo pill, and researchers measured changes in bowel symptoms and colon inflammation. Th…
Phase: PHASE2 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New acne gel put to the test against leading treatment
Disease control CompletedThis study tested a new topical gel called IDP-126 for treating moderate to severe acne. It directly compared the new gel to a commonly used treatment, Epiduo Forte, and a placebo gel. The 12-week trial involved 686 participants aged 12 and older to see which treatment was more e…
Phase: PHASE2 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New hope for Kids' tummy troubles?
Symptom relief CompletedThis study tested whether a medication called plecanatide could help children and teenagers with irritable bowel syndrome with constipation (IBS-C). Researchers compared different doses of the drug to a placebo (a dummy pill) to see if it increased bowel movements and reduced abd…
Phase: PHASE2 • Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC